Top Trending Tickers On StockTwits For March 14

Here's a look at the top tickers trending on StockTwits.com. Teva Pharmaceutical: CEO hosts UK and Israeli leaders Teva Pharmaceuticals TEVA announced a collaboration between Teva and the United Kingdom Government's National Health Service National Institute for Health Research (NIHR) and the Office for Clinical Research Infrastructure (NOCRI) The collaboration was announced on Thursday when Teva's CEP Erez Vigodman hosted UK Prime Minister David Cameron and Israeli Prime Minister Binyamin Netenyahu. According to Teva's official press release, The UK is a well-established world-leader in high quality clinical research. However, recognizing the need to constantly innovate and improve, NOCRI has created a novel model that streamlines the approach to undertaking clinical development in the UK. The new model provides a single point of entry into the UK healthcare system that cuts out the inherent complexities and inefficiencies of dealing with many and varied stakeholders within the combined medical and academic network on an individual and centre by centre basis. Teva has an extensive clinical stage pipeline that is being developed globally and as part of this collaboration plans to spend approximately $20 million on conducting trials in the UK. Shares were trading higher by 0.58 percent in the pre-market session. Ariad: Market chatter persists On Tuesday, Ariad Pharmaceuticals ARIA reported its fourth quarter results which included a beat on the top and bottom line. Investors appear to be paying closer attention to comments management made during its conference call: "In addition to actively pursuing distribution agreements for Iclusig in central and eastern Europe, as well as in the Middle East, just as we have done in Australia, we plan to partner Iclusig in Japan and perhaps in other countries in Asia. We have no timeframe now on when we might announce a partnership, but we consider this decision as an important step in building shareholder value." Management's comments confirm earlier speculation that the company is actively seeking a partner in Japan for Iclusig. The Stock Twit community continues to speculate if a major announcement is in the horizon or not. “$ARIA Give Iclusig some time to generate revenue again, will easily hit $12 within the next 4 months,” said a member. “$ARIA Below the 50MA. I love this stock as much as you do but this is not the time to be long in this one,” cautioned another. Shares were trading lower by 2.00 percent in the pre-market session. General Mills: Business as usual This morning, General Mills GIS reaffirmed its prior guidance of fiscal 2014 EPS of $2.87 to $2.90. Sales and operating profit for the third quarter may come in one percent lower reflecting a drop in volume. The company will report its third quarter results on March 19 with a conference call scheduled at 8:30 AM ET. Shares were trading lower by 3.23 percent in the pre-market session. Ebix: Investors happy with quarterly results This morning, Ebix EBIX reported its fourth quarter results. The company announced an EPS of $0.40, beating the consensus estimate of $0.32. Revenue of $50.8 million was in-line with the consensus estimate. Net income for the quarter fell to $15.2 million from $18.7 million in the same quarter last year. Earnings were impacted primarily due to the strengthening of the US dollar compared to the Australian dollar and Brazilian Real. Management noted that they remain “cautiously optimistic” about the future and 2013 was a “good test of the inherent fundamental strength of Ebix's strong network of clients, products and client relationships.” Shares were trading higher by 0.47 percent in the pre-market session. S&P 500: What to expect Stock futures were indicating that equities would continue where markets left off following yesterday's selloff. The Nikkei fell 3.3 percent overnight while Shanghai fell 0.75 percent. Europe is trading lower with the Stoxx 50 down around 0.6 percent. Treasury yields are steady at 2.66 percent with gold relatively unchanged. Traders and investors continue to monitor the Crimea situation with a referendum to take place over the weekend where Crimea citizens will vote to declare independence from Ukraine. Shares of the S&P 500 ETF, SPDR S&P 500 SPY were trading lower by 0.26 percent in the pre-market session.